NYU Epilepsy Self-Management Study
Economic Evaluation of Managing Epilepsy Well (MEW) Network Epilepsy Self-Management Programs
NYU Langone Health
108 participants
Sep 16, 2025
INTERVENTIONAL
Conditions
Summary
The investigators will conduct two-arm randomized controlled trials (RCTs) comparing effects of UPLIFT vs. enhanced usual care and PACES vs. enhanced usual care, respectively, on quality of life, depressive symptoms and seizures over 12 months in NYU patients with epilepsy.
Eligibility
Inclusion Criteria5
- Adults (≥18 years)
- English-speaking (UPLIFT and PACES) or Spanish-speaking (UPLIFT only).
- Diagnosed with epilepsy for at least one year
- Able to understand the informed consent and provide consent
- Elevated depressive symptoms - Patient Health Questionnaire-9 (PHQ-9) score ≥10; applies to UPLIFT only
Exclusion Criteria4
- Severe depressive symptoms (score of ≥20 on PHQ-9)
- Active suicidal ideation (score of ≥1 on PHQ-9 item #9 or otherwise reported during screening)
- Active psychotic disorder (psychiatric diagnosis and/or antipsychotic medications in the electronic health records (EHR)
- Significant cognitive impairment (indicated in the EHR or evident during screening)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
UPLIFT is an 8-week epilepsy self-management programs delivered to small groups of people with epilepsy (PWE) by Webex. UPLIFT is focused on self-management of depressive symptoms. Each weekly session is 1 hour long and is comprised of a check-in period, teaching on the week's topic, group discussion, a skill-building exercise and a home practice assignment.
PACES is an 8-week epilepsy self-management programs delivered to small groups of people with epilepsy (PWE) by Webex. PACES focuses on general epilepsy self-management. Each weekly session is 1 hour long and is comprised of a check-in period, teaching on the week's topic, group discussion, a skill-building exercise and a home practice assignment.
Participants receive referrals to local epilepsy support groups.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07087821